Humanigen (HGEN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

533 AIRPORT BLVD. BURLINGAME, CA 94010

Humanigen, Inc. operates as a biopharmaceutical company. The Company focuses on advancing medicines for patients with neglected and rare diseases. Humanigen develops monoclonal antibodies designed for patients with difficult-to-treat diseases, including respiratory diseases, parasitic infection, and hematologic cancer. Humanigen serves health care industry throughout the United States.

Data as of 2021-05-08 11:19:36 -0400
Market Cap1.136 Billion Shares Outstanding58.657 Million Avg 30-day Volume1.327 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE3.71 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low29.2 / 7.75 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from HGEN instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 4 -75.0% 1 (0.06%) 4 (0.25%) -75.0%
Funds Holding: 39 28 39.29% 10 (0.6%) 15 (0.93%) -33.33%
13F shares: 13.091 Million 15.577 Million -15.96% 9.689 Million 14.669 Million -33.95%
% Ownership 26.0823 19.3037
New Positions: 23 26 -11.54% 3 14 -78.57%
Increased Positions 6 3
Closed Positions 11 7
Reduced Positions 4 1 300.0% 2 1 100.0%
Total Calls 114.104 Thousand 0 67.7 Thousand
Total Puts 169.921 Thousand 0 75.1 Thousand
PUT/CALL Ratio 1.49 1.11
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding HGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HGEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

119.2 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KILCOYNE ADRIAN CHIEF MEDICAL OFFICER

0 2021-04-21 2

DURRANT CAMERON CHIEF EXECUTIVE OFFICER

652,640 2021-03-12 3

NOMIS BAY LTD.

  • 10% Owner
60,975,356 2021-03-09 22

BARLIANT RONALD

0 2020-09-30 2

BOEHM RAINER J.

84,986 2020-09-30 1

BUXTON CHERYL

4,364 2020-09-30 1

MORRIS TIMOTHY E COO AND CFO

0 2020-09-18 1

CHAPPELL DALE CHIEF SCIENTIFIC OFFICER

0 2020-09-18 1

TOUSLEY DAVID L. SEE REMARKS

0 2020-09-18 2

JORDAN EDWARD P. CHIEF COMMERCIAL OFFICER

0 2020-09-18 2

SAVAGE ROBERT G.

0 2020-04-01 0

CHAPPELL DALE

CHEVAL HOLDINGS, LTD.

BLACK HORSE CAPITAL MANAGEMENT LLC

49,636,917 2019-12-11 0

JESTER J GREGORY CHIEF FINANCIAL OFFICER

0 2019-01-25 0

CHAPPELL DALE

BLACK HORSE CAPITAL MANAGEMENT LLC

BLACK HORSE CAPITAL MASTER FUND LTD.

CHEVAL HOLDINGS, LTD.

BLACK HORSE CAPITAL LP

  • 10% Owner
66,870,851 2018-02-27 1

LAM MORGAN CHIEF SCIENTIFIC OFFICER

  • Officer
0 2017-02-21 0

FRIEDBERG EZRA M

  • Director
0 2016-09-13 0

SHKRELI MARTIN

  • 10% Owner
0 2016-08-25 0

WITTER DEAN III INTERIM CHIEF FINANCIAL OFCR

  • Officer
0 2016-01-07 0

ANTHION PARTNERS II LLC

MORADI DAVID

  • Director
  • 10% Owner
1,156,420 2015-12-16 0

BIESTEK MAREK

  • Director
  • SEE REMARKS
250,000 2015-12-16 0

FERNANDEZ THOMAS EDWARD

  • Director
6,821 2015-12-16 0

HARRISON MICHAEL WAYNE

  • Director
1,705 2015-12-16 0

CHASE ANTHONY R

  • Director
0 2015-11-19 0

ANTHION PARTNERS II LLC

  • 10% Owner
849,600 2015-11-16 0

CROSS HERB CHIEF FINANCIAL OFFICER

  • Officer
0 2015-11-09 0

MARTELL RON EXECUTIVE CHAIRMAN

  • Officer
  • Director
0 2015-10-28 0

LOVE TED W

  • Director
0 2015-07-10 0

WITHY RAYMOND M

  • Director
0 2015-07-10 0

GILBERT DENISE

  • Director
0 2015-07-10 0

LYONS GARY A

  • Director
0 2015-07-10 0

SMALDONE ALSUP LAURIE

  • Director
0 2015-07-10 0

BAFFI ROBERT

  • Director
0 2015-07-10 0

YARRANTON GEOFFREY THOMAS CHIEF SCIENTIFIC OFFICER

  • Officer
0 2015-02-16 0

JOSEPH DONALD CHIEF LEGAL OFFICER

  • Officer
0 2015-02-16 0

LAWLIS V BRYAN

  • Director
0 2014-06-18 0

PRITCHARD DAVID CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2014-01-21 0

MOLFINO NESTOR CHIEF MEDICAL OFFICER

  • Officer
0 2014-01-19 0

SMITH BRIGITTE

  • Director
No longer subject to file 2013-08-07 0

HENNER DENNIS

  • Director
  • 10% Owner
0 2013-05-01 0

HEALY JAMES

  • Director
0 2013-04-30 0

COOPER JEFFREY H CHIEF FINANCIAL OFFICER

  • Officer
0 2013-04-30 0

MPM BIOVENTURES III-QP L.P.

MPM BIOVENTURES III L.P.

MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES III PARALLEL FUND, L.P.

MPM ASSET MANAGEMENT INVESTORS 2005 BVIII LLC

MPM BIOVENTURES STRATEGIC FUND LP

MPM BIOVENTURES III GP L.P.

MPM BIOVENTURES III LLC

  • 10% Owner
2,632,928 2013-02-05 0

EVNIN LUKE

GADICKE ANSBERT

GALAKATOS NICHOLAS

SIMON NICHOLAS J III

STEINMETZ MICHAEL

WHEELER KURT

  • 10% Owner
2,632,928 2013-02-05 0

LEHMAN BROTHERS HOLDINGS INC.

  • FORMER 10% OWNER
No longer subject to file 2013-02-05 0

SINGAPORE BIO INNOVATIONS PTE LTD

EDB INVESTMENTS PTE LTD.

  • 10% Owner
No longer subject to file 2013-02-05 0

SOFINNOVA VENTURE PARTNERS V LP

SOFINNOVA VENTURE AFFILIATES V LP

SOFINNOVA VENTURE PRINCIPALS V LP

SOFINNOVA MANAGEMENT V LLC

SOFINNOVA MANAGEMENT V 2005, LLC

AZAN ALAIN

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2013-02-05 0

MITSUBISHI UFJ CAPITAL II, LIMITED PARTNERSHIP

  • 10% Owner
No longer subject to file 2013-02-05 0

BAXTER INTERNATIONAL INC

  • 10% Owner
No longer subject to file 2013-02-05 0

DEVELOPMENT BANK OF JAPAN INC.

  • 10% Owner
No longer subject to file 2013-02-05 0

GBS VENTURE PARTNERS PTY, LTD

GBS BIOVENTURES II A/C

GENESIS FUND

  • 10% Owner
No longer subject to file 2013-02-05 0

ALLOY VENTURES 2000, LLC

ALLOY ANNEX I, LLC

ALLOY ANNEX I, L.P.

ALLOY CORPORATE 2000, L.P.

ALLOY INVESTORS 2000, L.P.

ALLOY PARTNERS 2000, L.P.

ALLOY VENTURES 2000, L.P.

  • 10% Owner
No longer subject to file 2013-02-05 0

5AM PARTNERS LLC

  • 10% Owner
No longer subject to file 2013-02-05 0

GBS VENTURE PARTNERS PTY, LTD

GBS BIOVENTURES II A/C

  • 10% Owner
25,000 2013-01-31 0

5AM PARTNERS LLC

5AM CO INVESTORS LLC

5AM VENTURES LLC

  • 10% Owner
223,190 2013-01-31 0

HEALY JAMES

SOFINNOVA VENTURE PARTNERS V LP

SOFINNOVA VENTURE AFFILIATES V LP

SOFINNOVA VENTURE PRINCIPALS V LP

SOFINNOVA MANAGEMENT V LLC

SOFINNOVA MANAGEMENT V 2005, LLC

  • Director
  • 10% Owner
382,979 2013-01-31 0

SANOFI

  • FORMER 10% OWNER
No longer subject to file 2013-01-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KILCOYNE ADRIAN CHIEF MEDICAL OFFICER

2021-04-22 16:44:44 -0400 2021-04-21 A 155,000 a 155,000 direct

DURRANT CAMERON CHIEF EXECUTIVE OFFICER

2021-03-15 17:51:17 -0400 2021-03-12 A 652,640 a 652,640 direct

NOMIS BAY LTD. - > 10% Owner

2021-03-11 20:24:15 -0500 2021-03-11 S 119,201 $16.02 d 5,380,799 direct 10.3298 -4.1693 4.4182 34.8787 13 -19.6951 9

NOMIS BAY LTD. - > 10% Owner

2021-03-11 20:24:15 -0500 2021-03-11 J 37,912 $15.49 d 5,342,887 direct 10.3298 -4.1693 4.4182 34.8787 13 -19.6951 9

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
HUMANIGEN INC HGEN 2021-05-10 22:15:04 UTC -6.0256 6.0756 1100000
HUMANIGEN INC HGEN 2021-05-10 21:45:02 UTC -6.0256 6.0756 1100000
HUMANIGEN INC HGEN 2021-05-10 21:15:02 UTC -6.0256 6.0756 1100000
HUMANIGEN INC HGEN 2021-05-10 20:45:03 UTC -6.0256 6.0756 1100000
HUMANIGEN INC HGEN 2021-05-10 20:15:03 UTC -6.0256 6.0756 1100000
HUMANIGEN INC HGEN 2021-05-10 19:45:03 UTC -6.0256 6.0756 1100000
HUMANIGEN INC HGEN 2021-05-10 19:15:03 UTC -6.0256 6.0756 1100000
HUMANIGEN INC HGEN 2021-05-10 18:45:03 UTC -4.4673 4.5173 1100000
HUMANIGEN INC HGEN 2021-05-10 18:15:03 UTC -4.4673 4.5173 1100000
HUMANIGEN INC HGEN 2021-05-10 17:45:02 UTC -4.4673 4.5173 1100000
HUMANIGEN INC HGEN 2021-05-10 17:15:03 UTC -4.4673 4.5173 1100000
HUMANIGEN INC HGEN 2021-05-10 16:45:03 UTC -4.4673 4.5173 1100000
HUMANIGEN INC HGEN 2021-05-10 16:15:03 UTC -4.4673 4.5173 1100000
HUMANIGEN INC HGEN 2021-05-10 15:45:03 UTC -4.4673 4.5173 1100000
HUMANIGEN INC HGEN 2021-05-10 15:15:03 UTC -4.4673 4.5173 1100000
HUMANIGEN INC HGEN 2021-05-10 14:45:04 UTC -4.3518 4.4018 1100000
HUMANIGEN INC HGEN 2021-05-10 14:15:04 UTC -4.3518 4.4018 1100000
HUMANIGEN INC HGEN 2021-05-10 13:45:04 UTC -4.3518 4.4018 1100000
HUMANIGEN INC HGEN 2021-05-10 13:15:03 UTC -4.3518 4.4018 1100000
HUMANIGEN INC HGEN 2021-05-10 12:45:02 UTC -4.3518 4.4018 900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund HGEN -4200.0 shares, $-80220.0 2021-03-31 N-PORT

Elevate your investments